Loss of LMO7 function can induce cycle arrest and apoptosis of pancreatic cancer cells, making LMO7 has become a promising target for pancreatic cancer therapy (Liu et al., 2021). The gene discussed is LMO7; the disease is pancreatic neoplasm.